Therapeutic Areas: Gastroenterology | Oncology | Hepatology (Liver, Pancreatic, Gall Bladder)

Digestive System Neoplasms Clinical Trials


A listing of Digestive System Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Mayo Clinic Arizona

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Phoenix : Mayo Clinic Arizona Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

California

Los Angeles : UCLA Department of Medicine Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Sacramento : University of California Davis Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco : University of California San Francisco Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Colorado

Aurora : University of Colorado Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Connecticut

New Haven : Yale Cancer Center

A clinical trial to evaluate treatments using Sorafenib, Capecitabine for patients with Metastatic Breast Cancer or Gastrointestinal Tumors

New Haven : Yale University School of Medicine Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

District of Columbia

Washington : DC Endoscopy Center

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Florida

Boca Raton : Lynn Cancer Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Myers : Florida Cancer Specialists Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville : University of Florida Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami : University of Miami

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Miami : UM Sylvester Comprehensive Cancer Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando : Florida Hospital Cancer Institute Memorial System Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St. Petersburg : Florida Cancer Specialists Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Georgia

Atlanta : Northside Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Atlanta : Emory University Winship Cancer Institute

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Arlington Heights : Illinois Cancer Specialists Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago : University of Chicago Medicine

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago : University of Chicago Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Evanston : NorthShore University Health System

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Evanston : Northshore University Healthsystem Research Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Indiana

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Iowa

Iowa City : Updated

A clinical research study of [68Ga]MLN6907 for the treatment of Imaging of Solid Gastrointestinal Tumors

Louisiana

Baton Rouge : Gastroenterology Associates, LLC

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New Orleans : Ochsner Cancer Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Maryland

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Chevy Chase : Chevy Chase Endoscopy Center

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Chevy Chase : MGG Group, Co. Inc./Chevy Chase Clinical Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Massachusetts

Boston : Massachusetts General Hospital Cancer Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Beth Israel Deaconess Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Dana Farber Cancer Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Michigan

Ann Arbor : University of Michigan Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit : Karmanos Cancer Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Farmington Hills : Detroit Clinical Research Center, PC

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Clinic

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

Rochester : Mayo Clinic

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Rochester : Mayo Clinic - Rochester Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Missouri

Mexico : Center for Digestive and Liver Diseases, Inc

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Nebraska

Omaha : Methodist Cancer Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Jersey

Livingston : Saint Barnabas Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Mexico

Albuquerque : Updated

A clinical research study of [68Ga]MLN6907 for the treatment of Imaging of Solid Gastrointestinal Tumors

New York

Buffalo : Roswell Park Cancer Institute Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lake Success : NYU Langone Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York : Memorial Sloan-Kettering Cancer Center

A clinical research study of TAS-102 and CPT-11 for the treatment of Advanced Gastrointestinal Tumors

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New York : Columbia University Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rochester : University of Rochester Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

North Carolina

Asheville : Asheville Gastroeneterology Associates

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Winston-Salem : Wake Forest Baptist Health Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ohio

Cincinnati : Oncology Hematology Care Inc. Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Cleveland Clinic Foundation Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Comprehensive Cancer Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Oklahoma

Oklahoma City : University of Oklahoma Peggy and Charles Stephenson Cancer Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Oregon

Portland : Oregon Health and Sciences University Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pennsylvania

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pittsburgh : UPMC Cancer Pavillion Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tennessee

Chattanooga : Tennessee Oncology - Chattanooga Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Knoxville : The University of Tennessee Medical Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nashville : Vanderbilt University Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Tennessee Oncology PLLC Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Texas

Dallas : UT Southwestern Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : Texas Oncology Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Worth : Center for Cancer and Blood Disorders Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Houston : Baylor Clinic Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tyler : Texas Oncology P.A. - Tyler Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Virginia

Charlottesville : University of Virginia Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lynchburg : Blue Ridge Medical Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Washington

Seattle : Seattle Cancer Care Alliance Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wisconsin

Madison : University of Wisconsin Hospital and Clinics

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Madison : University of Wisconsin Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milwaukee : Wisconsin Center for Advanced Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Australia

Bentleigh East : Monash Medical Centre Moorabbin Campus Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Garran : The Canberra Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Herston : Royal Brisbane & Women's Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malvern : Cabrini Hospital Malvern Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

South Brisbane : Icon Cancer Care South Brisbane Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St Leonards : Northern Cancer Institute, St Leonards Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Subiaco : St John of God Hospital Subiaco Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sydney : Prince of Wales Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Austria

Graz : Medizinische Universität Graz Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Innsbruck : Universitätsklinikum Innsbruck Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Linz : A.ö. Krankenhaus der Elisabethinen Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Salzburg : Salzburger Landeskliniken Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wels : Klinikum Wels-Grieskirchen GmbH Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wien : Kaiser Franz Josef Spital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wien : Medizinische Universität Wien Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Belgium

Brussels : Hôpital Erasme Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Edegem : UZ Antwerpen Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gent : UZ Gent Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Leuven : UZ Leuven Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Canada

Calgary : Tom Baker Cancer Centre Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Montreal : CHUM Hôpital Saint-Luc Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Montreal : Jewish General Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Toronto : Princess Margaret Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

China

Guangzhou : Affiliated Tumor Hospital of Guangzhou Medical University Immunotherapy center

A clinical trial to evaluate treatments using Chemotherapy and Ag-D-CIK for patients

Jingzhou : Jingzhou Central Hospital Immunotherapy center

A clinical trial to evaluate treatments using Chemotherapy and Ag-D-CIK for patients

Jingzhou : Jingzhou Central Hospital Immunotherapy center

A Phase 2 clinical study for patients using DC-CIK, Radiotherapy and Chemotherapy

Czech Republic

Hradec Kralove : Fakultni nemocnice Hradec Kralove Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Liberec : Krajska nemocnice Liberec, a.s. Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Zlin : Krajska nemocnice T. Bati a.s. Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Denmark

Ålborg : Aalborg Universitetshospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Herlev : Herlev Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Finland

Helsinki : Helsingin Yliopistollinen Keskussairaala Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampere : Tampereen yliopistollinen sairaala Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Turku : Turun Yliopistollinen Keskussairaala Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

France

Angers cedex 12 : CHU Angers Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Créteil : Hopital Henri Mondor Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lille : CHRU Lille Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon : Hopital prive Jean Mermoz Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon Cedex 06 : Groupement Hospitalier Edouard Herriot Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Groupe Hospitalier Pitie Salpetriere Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Hôpital Européen Georges Pompidou Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Mutualiste Montsouris Institute

Patients are needed to participate in a clinical research study of confocal laser endomicroscopy to evaluate Cancer of Digestive System or Ovarian Cancer (PERSEE)

Poitiers : CHRU de Poitiers La Miletrie Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Germany

Berlin : Charité - Universitätsmedizin Berlin Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Berlin : Charité - Universitätsmedizin Berlin Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dresden : Universitätsklinikum Carl Gustav Carus an der TU Dresden Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Essen : Kliniken Essen Mitte Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Frechen : Praxis Internistischer Onkologie und Hämatologie Frechen Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Friedrichshafen : Praxis für Innere Medizin Droettle Helmut Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Greifswald : Universität Greifswald Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Hamburg : Universitätsklinikum Hamburg Eppendorf Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Köln : Praxis Internistischer Onkologie und Hämatologie Köln Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Mainz : Universitätsmedizin der Johannes Gutenberg-Universität Mainz Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

München : Klinikum Neuperlach Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Würzburg : Universitätsklinikum Würzburg Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Hong Kong

Hong Kong : Queen Mary Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Hungary

Budapest : Uzsoki Utcai Kórház Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Debrecen : Debreceni Egyetem Orvos-és Egészségtudományi Centrum Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ireland

Dublin : Saint Vincent's University Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Italy

Ancona : Az Osp University Ospedali Riuniti umberto I GM Lancisi Gsalesi Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Firenze : Azienda Ospedaliera Universitaria Careggi Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Meldola : Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milano : Azienda Ospedaliera Niguarda Cà Granda Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milano : Ospedale San Raffaele S.r.l. Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pisa : Cisanello Hospital, Division of Diagnostic Imaging and Intervention Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Pisa : Azienda Ospedaliero Universitaria Pisana Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Reggio Emilia : Arcispedale Santa Maria Nuova Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Roma : Istituto Nazionale Tumori Regina Elena Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rozzano : Istituto Clinico Humanitas Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Giovanni Rotondo : Ospedale Casa Sollievo Della Sofferenza IRCCS Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Terni : Azienda Ospedaliera S Maria Di Terni Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Verona : Azienda Ospedaliera Universitaria Integrata Di Verona Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Korea, Republic of

Anyang : Hallym University Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastrointestinal Neoplasms

Busan : Pusan National University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Daegu : Kyungpook National University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Daegu : Kyungpook National University Medical Center Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Gangnam-Gu, Seoul : GangNam Severance Hospital

Patients are needed to participate in a clinical research study evaluating Monosyn for the treatment of C.Surgical Procedure; Digestive System, Symptomatic Disorders of the Gastrointestinal Tract, Gastric Anastomosis (Site) or Gastrointestinal Neoplasms

Goyang-si : Inje University Ilsan Paik Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Gyeonggi-do : Seoul National University Bundang Hospital

Patients are needed to participate in a clinical research study evaluating Monosyn for the treatment of C.Surgical Procedure; Digestive System, Symptomatic Disorders of the Gastrointestinal Tract, Gastric Anastomosis (Site) or Gastrointestinal Neoplasms

Incheon : Inha University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Severance Hospital, Yonsei University Health System Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Seoul National University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : The Catholic University of Korea, Seoul St.Mary's Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Korea University Anam Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Samsung Medical Center Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Seoul National University Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seoul : Samsung Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seoul : Asan Medical Center Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malaysia

Kuala Lumpur : University Malaya Medical Centre Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Kuala Lumpur : University Malaya Medical Centre

Patients are needed to participate in a clinical research study evaluating Monosyn for the treatment of C.Surgical Procedure; Digestive System, Symptomatic Disorders of the Gastrointestinal Tract, Gastric Anastomosis (Site) or Gastrointestinal Neoplasms

Negeri Sembilan : Nilai Medical Centre Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Philippines

Manila : Chinese General Hospital and Medical Center Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Manila : Philippine General Hospital

Patients are needed to participate in a clinical research study evaluating Monosyn for the treatment of C.Surgical Procedure; Digestive System, Symptomatic Disorders of the Gastrointestinal Tract, Gastric Anastomosis (Site) or Gastrointestinal Neoplasms

Metro Manila : The Medical City Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Quezon City : St. Lukes Medical Center Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

San Juan : Cardinal Santos Medical Center Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Portugal

Lisbao : Hospital Da Luz Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lisboa : Centro Hospitalar de Lisboa Central Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Porto : Centro Hospitalar de Sao Joao EPE Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Spain

Barcelona : Hospital Clinic de Barcelona Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Hospital Universitario Vall d'Hebron Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Instituto Catalan de Oncologia de Hospitalet (ICO) : Instituto Catalan de Oncologia de Hospitalet (ICO) Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario La Paz Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Madrid : Hospital Madrid Norte Sanchinarro Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Madrid : Hospital Universitario 12 de Octubre Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Centro Integral Oncologico Clara Campal Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario Ramon y Cajal Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital General Universitario Gregorio Marañón Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malaga : Hospital Regional Universitario de Malaga Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pamplona : Complejo Hospitalario de Navarra Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santander : Hospital Universitario Marques de Valdecilla Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santiago de Compostela : Hospital Clinico Universitario de Santiago Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sevilla : Hospital Virgen del Rocio Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Switzerland

Berne : Department of visceral surgery and transplant surgery, Berne University Hospital

A Phase 4 clinical study for patients with Malnourishment or Gastrointestinal Tumors

Taiwan

Douliou City : National Taiwan University Hospital, Yun-Lin Branch Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taichung : Taichung Veteran General Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taichung : China Medical University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Tainan : National Cheng Kung University (NCKU) Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Tainan City : National Cheng Kung University Hosptial Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Taipei : Mackay Memorial Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taipei City : National Taiwan University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taipei City : Veterans General Hospital-Taipei

Patients are needed to participate in a clinical research study evaluating Monosyn for the treatment of C.Surgical Procedure; Digestive System, Symptomatic Disorders of the Gastrointestinal Tract, Gastric Anastomosis (Site) or Gastrointestinal Neoplasms

Thailand

Bangkok : Siriraj Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Bangkok : Chulalongkorn University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Pathumthani : Thammasat University Hospital Updated

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

United Kingdom

Sheffield : Weston Park Hospital Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2